Steve Duffy

Digital Content Editor

Most Recent Articles by Steve Duffy

White House Unveils Plan to Lower Cost of Prescription Drugs

White House Unveils Plan to Lower Cost of Prescription Drugs

By

Proposals to lower prescription drug prices have been announced by President Trump.

Study IDs Unintended Consequence of Prescription Drug Monitoring Programs

Study IDs Unintended Consequence of Prescription Drug Monitoring Programs

By

Evidence on whether the implementation of prescription drug monitory programs increases or decreases opioid-related overdoses was found to be "largely insufficient".

Phase 3 Results Released for Investigational Alzheimer Disease Treatment

Phase 3 Results Released for Investigational Alzheimer Disease Treatment

By

Results showed that after 18-months, there was no significant statistical difference in cognitive or functional outcomes between those patients taking azeliragon and the placebo group.

Firdapse NDA Submitted for Lambert-Eaton Myasthenic Syndrome

Firdapse NDA Submitted for Lambert-Eaton Myasthenic Syndrome

By

Results from the Phase 3 trial showed that the Quantitative Myasthenia Gravis (QMG) score at baseline to day 14 changed from 6.4 to 6.7 in the amifampridine group vs. 5.6 to 7.9 for the placebo group.

FDA Fast Tracks Treatment for Fragile X Syndrome

FDA Fast Tracks Treatment for Fragile X Syndrome

By

OV101 has previously been granted Orphan Drug status for Fragile X and Fast Track status for Angelman syndrome.

More Articles by Steve Duffy

Sign Up for Free e-newsletters

CME Focus